The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 36.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 44%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (13 analysts) rates it strong buy, with a mean price target of $68.
IonQ Inc
IONQ · the NYSE · USD · Market cap $15.2B · 1,132 employees
IonQ, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-02
Screened 2026-09-02 · the tape above runs as of 00:54 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
IonQ Inc holds its Markdown at $37.64. Elevated stress, defensive posture warranted, held for 239 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 239 days |
| Price at the screen | $37.64 |
| Valuation | N/A trailing · -30.99 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 3.30 |
Five Screens, Shown in Full
Does not pass. Revenue purity
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.46% | Below 33% | Interest-bearing debt is just 0.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 20.72% | Below 33% | Cash held in interest-bearing accounts and securities is 20.7% of assets, under the one-third limit. | Pass |
| Receivables | 16.20% | Below 49% | Money owed to the company is 16.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 43.07% | Below 5% | 43.1% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-02 screen. The gold marker is the market price at the same screen. A 72.7% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus Strong Buy. The average target sits +73% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsQuantum Growth Story Hides Persistent Losses
Imagine booking time on a machine that can solve problems no ordinary computer can touch. IonQ sells exactly that access through cloud partners, and its revenue has jumped 755 percent while the ethical screen clears without issue.
Yet the opportunity rating sits at none. Forward earnings stay negative at minus 31.6 times, the moat is narrow, and return on equity barely clears 11 percent. A reported profit margin of 175 percent looks more like an accounting spike than a repeatable result.
Analysts may cluster around a 68 dollar target, but the business still depends on early-stage hardware that has not proved durable economics. High growth alone does not offset the fragility. Analysis, not advice.
| Forward P/E | -31.0x |
| EPS, trailing | -3.87 |
| EPS, forward | -1.21 |
| Revenue growth | +286.8%growing very fast |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -60.5%not currently earning a positive return on equity |
| FCF yield | -0.58% |
| Debt to equity | 1.63a meaningful debt load worth watching |
| Current ratio | 10.66comfortably covers its short-term bills |
| Beta | 3.30much more volatile than the market |
| Short interest, float | 0.11% |
| 52-week range | 25.89 - 84.64 |
| Moat | NARROW |
| Market cap | $15.2B |
| Employees | 1,132 |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeIONQ trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 41.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 44%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (13 analysts) rates it strong buy, with a mean price target of $68.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 44%. Our forward projection puts the odds of a 10% gain over the next month near 46%. The street (13 analysts) rates it strong buy, with a mean price target of $68.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $56.89 | +0.5% | · | $1,005 | +0.5% |
| 2 months | $28.79 | +98.7% | · | $1,987 | +98.7% |
| 3 months | $33.03 | +73.2% | · | $1,732 | +73.2% |
| 6 months | $52.55 | +8.8% | · | $1,088 | +8.8% |
| 1 year | $39.74 | +43.9% | · | $1,439 | +43.9% |
| 2 years | $8.22 | +595.8% | · | $6,958 | +595.8% |
| 3 years | $10.55 | +442.1% | · | $5,421 | +442.1% |
| 5 years | $10.57 | +441.1% | · | $5,411 | +441.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever IONQ does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.